GI Screening/Surveillance in Lynch Syndrome

Similar documents
Quality of and compliance with colonoscopy in Lynch Syndrome surveillance: are we getting it right?

Hereditary Non Polyposis Colorectal Cancer(HNPCC) From clinic to genetics

Guidelines for the assessment of mismatch repair (MMR) status in Colorectal Cancer

Universal Screening for Lynch Syndrome

Familial and Hereditary Colon Cancer

FAMILIAL COLORECTAL CANCER. Lyn Schofield Manager Familial Cancer Registry

Content. Diagnostic approach and clinical management of Lynch Syndrome: guidelines. Terminology. Identification of Lynch Syndrome

Familial and Hereditary Colon Cancer

COLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer

COLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer

LYNCH SYNDROME: IN YOUR FACE BUT LOST IN SPACE (MOUNTAIN)!

Lynch Syndrome. Angie Strang, PGY2

For identification, support and follow up related to Familial Gastrointestinal Cancer conditions. South Island Cancer Nurses Network September 2013

Colon Cancer Screening. Layth Al-Jashaami, MD GI Fellow, PGY 4

Prevention of Bowel Cancer: which patients do I send for colonoscopy?

Yes when meets criteria below. Dean Health Plan covers when Medicare also covers the benefit.

Missed Lesions at Endoscopy. Dr Russell Walmsley, MD, FRCP, FRACP Gastroenterologist WDHB Chair Endoscopy Guidance Group for New Zealand

Colorectal Neoplasia. Dr. Smita Devani MBChB, MRCP. Consultant Physician and Gastroenterologist Aga Khan University Hospital, Nairobi

Quality Measures In Colonoscopy: Why Should I Care?

Post-colonoscopy colorectal cancers in Lynch syndrome

GENETIC MANAGEMENT OF A FAMILY HISTORY OF FAP or MUTYH ASSOCIATED POLYPOSIS. Family Health Clinical Genetics. Clinical Genetics department

DIAGNOSTICS ASSESSMENT PROGRAMME Diagnostics consultation document

Colonoscopy Quality Data

Guidelines on Genetic Evaluation and Management of Lynch Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer

Objectives. Definitions. Colorectal Cancer Screening 5/8/2018. Payam Afshar, MS, MD Kaiser Permanente, San Diego. Colorectal cancer background

Bowel cancer screening and prevention

Risk of Colorectal Cancer (CRC) Hereditary Syndromes in GI Cancer GENETIC MALPRACTICE

Genetic Testing for Lynch Syndrome

Serrated Polyps and a Classification of Colorectal Cancer

Lynch Syndrome. A Patient s Guide to Genetic Testing for Lynch Syndrome

COLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014

11/9/2015 OUTLINE. Quality Indicators for the Doctor Performing Screening Colonoscopy: What you should expect from your Endoscopist

COLON CANCER GENETICS (FOR SURGEONS) Mark W. Arnold MD Chief, Division of Colon and Rectal Surgery Professor of Surgery The Ohio State University

Mr Chris Wakeman. General Surgeon University of Otago, Christchurch. 12:15-12:40 Management of Colorectal Cancer

Assessment of Universal Mismatch repair (MMR) or Microsatellite Instability (MSI) testing in colorectal cancers.

LIST OF ABBREVIATIONS

Update from the 2011 symposium: MOH testing criteria

Diagnostics guidance Published: 22 February 2017 nice.org.uk/guidance/dg27

Prior Authorization. Additional Information:

ACG Clinical Guideline: Colorectal Cancer Screening

Pathology reports, related operative reports and consult letters must be provided with a request for assessment.

GENETICS OF COLORECTAL CANCER: HEREDITARY ASPECTS By. Magnitude of the Problem. Magnitude of the Problem. Cardinal Features of Lynch Syndrome

Colon Cancer Screening & Surveillance. Amit Patel, MD PGY-4 GI Fellow

FACT SHEET 49. What is meant by a family history of bowel cancer? What is bowel cancer? What causes bowel cancer?

Protocols 9-12 MMR mutation carrier guidelines Frequently asked questions

Case Presentation Diana Lim, MBBS, FRCPA, FRCPath Senior Consultant Department of Pathology, National University Health System, Singapore Assistant Pr

WEO CRC SC Meeting. Barcelona, Spain October 23, 2015

Heather Hampel, MS, CGC Professor, Division of Human Genetics

Colon Cancer Screening and Surveillance. Louis V. Antignano, M.D. Wilson Gastroenterology October 11, 2011

Genetic testing all you need to know

Colorectal Cancer - Working in Partnership. David Baty Genetics, Ninewells Hospital

Colonic polyps and colon cancer. Andrew Macpherson Director of Gastroentology University of Bern

Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer

Latest Endoscopic Guidelines for FAP, HNPCC, IBD, and the General Population

When is a programmed follow-up meaningful and how should it be done? Professor Alastair Watson University of Liverpool

Kenneth D. Chi, MD Medical Director, GI Lab Advocate Lutheran General Hospital Center for Digestive Health May 7, 2016

Colorectal Cancer Screening and Surveillance

Measure #425: Photodocumentation of Cecal Intubation National Quality Strategy Domain: Effective Clinical Care

How common are mutations in the MSH2 gene? 1. Mutations that cause Lynch syndrome are rare found in approximately 1 in 370 individuals.

Benchmarking For Colonoscopy. Technology and Technique to Improve Adenoma Detection

Primary Care Approach to Genetic Cancer Syndromes

Screening & Surveillance Guidelines

MSH6 gene. Associated Syndrome Name: Lynch syndrome/hereditary NonPolyposis Colorectal Cancer (HNPCC) MSH6 Summary Cancer Risk Table

A Review from the Genetic Counselor s Perspective

A Patient s Guide to Hereditary Cancer. Is Hereditary Cancer Testing Right for You?

Improving Access to Endoscopy at Safety-Net Hospitals. Lukejohn W. Day MD Assistant Professor of Medicine

UK Bowel Cancer screening Dr Voi Shim Wong BsC MD FRCP. Consultant Gastroenterologist Accredited BCSP colonoscopist Whittington + UCL Hospitals

Colonoscopy Quality Data 2017

Colorectal Cancer Screening

YES NO UNKNOWN. Stage I: Rule-Out Dashboard ACTIONABILITY PENETRANCE SIGNIFICANCE/BURDEN OF DISEASE NEXT STEPS. YES ( 1 of above)

2. Describe pros/cons of screening interventions (including colonoscopy, CT colography, fecal tests)

An Updated Approach to Colon Cancer Screening and Prevention

Policy Specific Section: Medical Necessity and Investigational / Experimental. October 14, 1998 March 28, 2014

CLINICAL FOCUS. Juvenile Polyposis. Winter 2009

MLH1 gene. Associated Syndrome Name: Lynch syndrome/hereditary NonPolyposis Colorectal Cancer (HNPCC) MLH1 Summary Cancer Risk Table

Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes

Extensive Surgery in LS factoring in gene and gender. Gabriela Möslein

M. Azzam Kayasseh,Dubai,UAE

Measure #425: Photodocumentation of Cecal Intubation National Quality Strategy Domain: Effective Clinical Care

Corporate Medical Policy

Prof Rupert Leong, Director of Endoscopy, Head of IBD Professor of Medicine UNSW, University of Sydney, Concord Hospital Australia IBDSydney

Incidence and Clinical Characteristics of Colonic and Extra Colonic Lynch Syndrome Manifestations in Uruguayan Mismatch Repair Carriers

Colorectal Cancer Syndromes. Barbara Jung, MD AGAF Associate Professor and Chief University of Illinois at Chicago

Management of higher risk of colorectal cancer. Huw Thomas

Result Navigator Positive Test Result: MSH6

2018 National Academy of Medicine Annual Meeting

Familial Risk and Colorectal Cancer Screening. December 8th, :00pm ET

Bowel Screening Colonoscopy in Glasgow How well are we doing? How well should we be doing? How can we evidence and improve performance?

A Patient s Guide to risk assessment. Hereditary Colorectal Cancer

The Whys OAP Annual Meeting CCO Symposium September 20. Immunohistochemical Assessment Dr. Terence Colgan Mount Sinai Hospital, Toronto

Understanding and Managing Lynch Syndrome

Supporting Information 2. ESGE QIC Lower GI Delphi voting process: Round 1 Working Group chair: Michal F. Kaminski, Poland

COLON CANCER SCREENING IN CYSTIC FIBROSIS

GI EMERGENCIES Acute Abdominal Pain

With CRC Screening Rates on the Rise, Quality Control Becomes Center of Attention

Colorectal Cancer Prevention Quantity and Quality Count

Colorectal Cancer Screening: Cost-Effectiveness and Adverse events October, 2005

Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP)

Transcription:

GI Screening/Surveillance in Lynch Syndrome M Appleyard Royal Brisbane and Women s Hospital Brisbane, Australia

GI Disease and Lynch Syndrome What are risks of GI disease in Lynch? Who do we screen for Lynch? Who do we put on endoscopy surveillance programs? National guidelines Evi-Q/NHMRC Why do we get interval cancers in Lynch patients Quality in colonoscopy

Why is Lynch Syndrome Important to Gastroenterologists Individuals have a genetic mutation in one of the DNA repair genes MLH1, PMS2, MSH2, or MSH6, and a lifetime risk for development of colorectal cancer of 25-75 % Increase risk of stomach and small bowel cancers, but much lower incidence

ancer MLH1 to age 70 yrs 1,2 MSH2 to age 70 yrs 1,2 MSH6 to age 70 yrs 3,2 PMS2 to age 70 yrs 4 Lynch syndrome to age 70 yrs* General population to age 85 yrs Colorectal (male) Colorectal (female) 34% 47% 22% 20% 38% 10%** 36% 37% 10% 15% 31% 6.6%** Endometrial 18% 30% 25% 15% 33% 2-3% Gastric 6% 0.2% 0-6% 1% Ovarian 8-15% 8-15% Low - 9% 1-2% Urothelial 0.2% 2.2% 0.7% - <3% 1% Small Bowel 0.4% 1.1% 0 - <3% 0.01% *This data does not take into account the impact of surveillance. Data Source: NSW Central Cancer Registry 2008 final dataset and NSW Health Outcomes Information Statistical Toolkit (HOIST).

So clearly the diagnosis of Lynch Syndrome comes with a significant GI cancer risk It is clearly important to recognise when patients might have Lynch Syndrome that might require referral for genetic testing When does a gastroenterologist worry about a new diagnosis of Lynch in a referred patient. In clinic or after colonoscopy?

Amsterdam II Criteria At least 3 relatives with Lynch cancers (colo-rectal cancer [CRC], endometrial, etc) one of whom is a first degree relative of the other 2 At least 2 successive generations affected At least one relative affected under the age of 50 years

Updated Bethesda Criteria CRC under 50 years Synchronous or metachronous CRC (or other Lynch-associated cancer) regardless of age CRC with MSI-H histology under age 60 CRC with one first degree relative with CRC or other Lynch-associated cancer with one of the cancers being diagnosed under 50 years CRC with two or more first or second degree relatives with CRC or other Lynch-associated cancers regardless of age

Histology

To Summarise Refer to clinical genetics Amsterdam II criteria CRC with updated Bethesda criteria and appropriate histology Gastrointestinal Endoscopy Surveillance Patients with documented mutation in DNA repair genes Some patients in whom we are very suspicious of Lynch Syndrome, but cannot confirm/find the genetic mutation

Endoscopy Procedures Colonoscopy Bowel prep Colonoscopy Gastroscopy Overnight fast Gastroscopy Capsule endoscopy

EVI-Q Guidelines Annual colonoscopy from age 25-30 (depending on mutation) or 5 years younger than youngest affected relative Biennial upper GI endoscopy from 30 for those with gastric cancer family history or with added ethnic risk No evidence for capsule endoscopy

NHMRC Guidelines Annual colonoscopy starting at 25 or 5 years prior than youngest affected relative Consider biennial upper GI endoscopy if family history No recommendation re capsule endoscopy

Quality of Colonoscopy is KPIs validated Important Caecal intubation > 90% Adenoma detection rate (<20% associated with increased interval cancer) Withdrawal time < 6minutes associated with lower adenoma detection High volume colonoscopists Good bowel prep Australia is about to recertify colonoscopists using these KPIs

Interval Cancer and Lynch Syndrome Colonoscopy can reduce the development of CRC by 63% in Lynch patients Interval cancer (cancer found in the colon within 2 years of a colonoscopy) is reported in Lynch Syndrome

Why do we get interval Ca in Right colon Polyps Flat surveillance patients? Small adenomas with advanced histology Short duration of polyp-crc sequence Synchronous Younger patients less tolerant of multiple colonoscopy

Flat Depressed Lesion, 7mm

Flat Depressed Lesion, 10mm

Where is a flat adenoma?

Colonoscopy in Lynch Patients Careful colonoscopists Complete colonoscopy Meticulous colonoscopy Slow withdrawal Careful inspection High resolution white light

RBWH Endoscopy Surveillance Protocol Annual colonoscopy from 25 or 5 years younger than youngest affected relative Biennial upper GI endoscopy Consider capsule endoscopy to visualise the small bowel in patients with a personal/strong family history of small bowel cancer

Summary In LS patients and individuals fulfilling the Amsterdam II criteria, surveillance colonoscopy should be performed using modern high resolution technology by experienced endoscopists every year, starting at age 25 years, or 5 years younger than the age of first diagnosis in the family (whichever is first)

Colonoscopy in LS patients should include meticulous inspection and precise removal of all polyps, with special attention to the right colon, alertness to flat lesions and using high resolution endoscopes

Get pictures of gastroscopy/colonoscopy/gi tract